{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T18:01:43Z","timestamp":1774548103833,"version":"3.50.1"},"reference-count":69,"publisher":"Mattioli1885","license":[{"start":{"date-parts":[[2021,1,15]],"date-time":"2021-01-15T00:00:00Z","timestamp":1610668800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Multidis Res Med"],"abstract":"<jats:p>Evidence-based management of bronchial asthma and wheezing in children and adults recommends the employment of inhaled corticosteroids (ICSs). Difficulty in using some inhalation devices for ICS delivery, such as pressurized metered-dose and dry-powder inhalers, is common among young children and in the elderly, and for that reason, they are replaced with nebulizers.\u00a0We reviewed comparative studies that evaluated funisolide with other ICSs currently available on the market, including beclomethasone dipropionate, fluticasone propionate, and budesonide. Moreover, we assessed the physicochemical properties of these ICSs in determining drug fate in the lung. Data indicate that the flunisolide output in respirable particles by any type of pneumatic nebulizer (traditional, open breath or breath-enhanced) is superior to the output of other ICSs. This is principally attributed to the higher water solubility of flunisolide. Furthermore, in vivo simulation studies demonstrate that the intersubject variability of the inhaled dose among asthmatic children was much greater for suspensions of fluticasone propionate and beclomethasone dipropionate than for those of flunisolide. The physicochemical properties and pharmacokinetic profile of flunisolide favor its employment in nebulization.<\/jats:p>","DOI":"10.4081\/mrm.2021.719","type":"journal-article","created":{"date-parts":[[2021,1,16]],"date-time":"2021-01-16T00:02:28Z","timestamp":1610755348000},"source":"Crossref","is-referenced-by-count":1,"title":["What makes flunisolide different among inhaled corticosteroids used for nebulization: a close look at the role of aqueous solubility"],"prefix":"10.5826","volume":"16","author":[{"given":"Ahmad","family":"Kantar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"27750","published-online":{"date-parts":[[2021,1,15]]},"reference":[{"key":"213","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00074905"},{"key":"214","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2005.05.004"},{"key":"215","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.1.335"},{"key":"216","unstructured":"Vermeire P. European trends in inhalation therapy. Eur Respir Rev 1994;4:89-91."},{"key":"217","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.03.012"},{"key":"218","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.01414"},{"key":"219","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12637"},{"key":"220","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(98)70156-3"},{"key":"221","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(93)90049-J"},{"key":"222","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.8.817"},{"key":"223","doi-asserted-by":"crossref","unstructured":"Ayres JG, Bateman ED, Lundback B, Harris TA. High dose fluticasone propionate, 1 mg daily versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. Eur Respir J 1995;8:579-86.","DOI":"10.1183\/09031936.95.08040579"},{"key":"224","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)80011-5"},{"key":"225","doi-asserted-by":"publisher","DOI":"10.1136\/adc.76.5.405"},{"key":"226","doi-asserted-by":"publisher","DOI":"10.1007\/BF00195931"},{"key":"227","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04393.x"},{"key":"228","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050287"},{"key":"229","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1997.d01-1425.x"},{"key":"230","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.96.09071427"},{"key":"231","doi-asserted-by":"publisher","DOI":"10.1136\/thx.51.3.262"},{"key":"232","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.1.55"},{"key":"233","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.1.9805106"},{"key":"234","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02581-2"},{"key":"235","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050407"},{"key":"236","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.98.11061342"},{"key":"237","doi-asserted-by":"publisher","DOI":"10.1136\/thx.48.5.506"},{"key":"238","unstructured":"Niven RW. Atomization and nebulizers. In: Hickey AJ, editor. Inhalation aerosol: Physical and biological basis for therapy. New York: Marcel Dekker; 1996. p. 273-312."},{"key":"239","doi-asserted-by":"publisher","DOI":"10.1136\/thx.52.suppl_2.31"},{"key":"240","unstructured":"Dalby RN, Tiano SL, Hickey AJ. Medical devices for the delivery of therapeutic aerosols to the lungs. In: Hickey AJ, editor. Inhalation aerosol: Physical and biological basis for therapy. New York: Marcel Dekker; 1996. p 441-73."},{"key":"241","unstructured":"Dhand R. Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care 2002;47:1406-146. discussion 1416-8."},{"key":"242","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.4_MeetingAbstracts.816S-b"},{"key":"243","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-010-9486-9"},{"key":"244","doi-asserted-by":"publisher","DOI":"10.1016\/S0169-409X(00)00103-4"},{"key":"245","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2006.03.007"},{"key":"246","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.00955"},{"key":"247","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.60.5.0005"},{"key":"248","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S114034"},{"key":"249","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06290"},{"key":"250","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.01.00231701"},{"key":"251","doi-asserted-by":"publisher","DOI":"10.1016\/0007-0971(86)90037-9"},{"key":"252","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016205520044"},{"key":"253","unstructured":"H\u00f6gger P, Rohdewald P. Glucocorticoid receptors and fluticasone propionate. Rev. Contemp Pharmacother 1998;9:501-22."},{"key":"254","unstructured":"O'Callaghan C, White J, Barry P, Kantar A. Analysis of the output of beclomethasone dipropionate from different nebulisers. Riv Ital Pediatr 2000;26:821-4."},{"key":"255","doi-asserted-by":"publisher","DOI":"10.1211\/0022357021778682"},{"key":"256","doi-asserted-by":"publisher","DOI":"10.1211\/0022357056190"},{"key":"257","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12208"},{"key":"258","doi-asserted-by":"publisher","DOI":"10.1136\/thx.45.2.109"},{"key":"259","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.55.4.345c"},{"key":"260","doi-asserted-by":"publisher","DOI":"10.1136\/adc.61.3.270"},{"key":"261","doi-asserted-by":"publisher","DOI":"10.1136\/adc.61.11.1108"},{"key":"262","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70009-6"},{"key":"263","doi-asserted-by":"publisher","DOI":"10.1201\/b14022-3"},{"key":"264","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2014.27"},{"key":"265","doi-asserted-by":"publisher","DOI":"10.1021\/mp200415g"},{"key":"266","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-012-9822-3"},{"key":"267","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2014.01.033"},{"key":"268","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2635-2"},{"key":"269","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(99)00230-8"},{"key":"270","unstructured":"Hallman M. Recycling of surfactant: A review of human amniotic fluid as a source of surfactant for treatment of respiratory distress syndrome. Rev Perinat Med 1989;6:197-226."},{"key":"271","unstructured":"Derendorf H, Hochhaus G, Krishnaswami S, Mo\u0308llmann H. Systemic disposition and effects of inhaled corticosteroids. In: Schleimer RP, O'Byrne PM, Szefler SJ, and Brattsand R, editors. Inhaled steroids in asthma. Optimizing effects in the airways. New York: Marcel Dekker; 2002. p. 247-72."},{"key":"272","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1995.tb04064.x"},{"key":"273","unstructured":"Miller-Larsson A, Mattsson H, Hjertberg E, Dahlb\u00e4ck M, Tunek A, Brattsand R. Reversible fatty acid conjugation of budesonide: Novel mechanism for prolonged retention of topically applied steroid in airway tissue. Drug Metab Dispos 1998;26:623-30."},{"key":"274","unstructured":"Hochberg RB. Biological esterification of Steroids. Endocr Rev 1998;19:331-48."},{"key":"275","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.162.4.9806112"},{"key":"276","unstructured":"Kelly HW. Comparative potency and clinical efficacy of inhaled corticosteroids. Respir Care Clin N Am 1999;5:537-53."},{"key":"277","doi-asserted-by":"publisher","DOI":"10.1177\/1721727X1201000116"},{"key":"278","doi-asserted-by":"publisher","DOI":"10.1080\/10611860290007504"},{"key":"279","doi-asserted-by":"publisher","DOI":"10.1002\/jps.10386"},{"key":"280","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-006-9013-6"},{"key":"281","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2007.28.2979"}],"container-title":["Multidisciplinary Respiratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/mrmjournal.org\/mrm\/article\/download\/719\/1235","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mrmjournal.org\/mrm\/article\/download\/719\/1239","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/mrmjournal.org\/index.php\/mrm\/article\/download\/719\/1235\/4011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T19:02:03Z","timestamp":1741374123000},"score":1,"resource":{"primary":{"URL":"https:\/\/mrmjournal.org\/index.php\/mrm\/article\/view\/719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,15]]},"references-count":69,"URL":"https:\/\/doi.org\/10.4081\/mrm.2021.719","relation":{},"ISSN":["2049-6958","1828-695X"],"issn-type":[{"value":"2049-6958","type":"electronic"},{"value":"1828-695X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,15]]}}}